Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord

被引:17
作者
Mauborgne, A [1 ]
Poliénor, H [1 ]
Hamon, M [1 ]
Cesselin, F [1 ]
Bourgoin, S [1 ]
机构
[1] INSERM, Fac Med Pitie Salpetriere, U 288, F-75634 Paris 13, France
关键词
adenosine receptor; K+-evoked release; substance P; (CGRP) calcitonin gene-related peptide; cholecystokinin; spinal cord; (rat);
D O I
10.1016/S0014-2999(01)01619-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although it is well established that adenosine exerts antinociceptive effects at the spinal level in various species including human, the mechanisms responsible for such effects are still a matter of debate. We presently investigated whether adenosine-induced antinociception might possibly be related to an inhibitory influence of this neuromodulator on the spinal release of neuropeptides implicated in the transfer and/or control of nociceptive signals. For this purpose, the K+-evoked overflow of substance P-, calcitonin gene-related peptide (CGR-P)-and cholecystokinin-like materials was measured from slices of the dorsal half of the rat lumbar enlargement superfused with an artificial cerebrospinal fluid supplemented with increasing concentrations of various adenosine receptor ligands. The data showed that stimulation of adenosine A(1) and (possibly) A(3) receptors, but not A(2A) receptors, exerted an inhibitory influence on the spinal release of CGRP-like material. In contrast, none of the adenosine A(1), A(2A) and A(3) receptor agonists tested within relevant ranges of concentrations significantly affected the release of substance P- and cholecystokinin-like materials. These results support the idea that adenosine-induced antinociception at the spinal level might possibly be caused, at least partly, by the stimulation of inhibitory adenosine A, receptors located presynaptically on primary afferent fibres containing CGRP but not substance P. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 54 条
  • [1] Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord
    Arvieu, L
    Mauborgne, A
    Bourgoin, S
    Oliver, C
    Feltz, P
    Hamon, M
    Cesselin, F
    [J]. NEUROREPORT, 1996, 7 (12) : 1973 - 1976
  • [2] The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain
    Belfrage, M
    Segerdahl, M
    Arnér, S
    Sollevi, A
    [J]. ANESTHESIA AND ANALGESIA, 1999, 89 (01) : 136 - 142
  • [3] MU-OPIOD AND DELTA-OPIOID RECEPTORS MEDIATE OPPOSITE MODULATIONS BY MORPHINE OF THE SPINAL RELEASE OF CHOLECYSTOKININ-LIKE MATERIAL
    BENOLIEL, JJ
    COLLIN, E
    MAUBORGNE, A
    BOURGOIN, S
    LEGRAND, JC
    HAMON, M
    CESSELIN, F
    [J]. BRAIN RESEARCH, 1994, 653 (1-2) : 81 - 91
  • [4] GABA, ACTING AT BOTH GABA(A) AND GABA(B) RECEPTORS, INHIBITS THE RELEASE OF CHOLECYSTOKININ-LIKE MATERIAL FROM THE RAT SPINAL-CORD INVITRO
    BENOLIEL, JJ
    BOURGOIN, S
    MAUBORGNE, A
    POHL, M
    LEGRAND, JC
    HAMON, M
    CESSELIN, F
    [J]. BRAIN RESEARCH, 1992, 590 (1-2) : 255 - 262
  • [5] MONOAMINERGIC CONTROL OF THE RELEASE OF CALCITONIN-GENE-RELATED PEPTIDE-LIKE AND SUBSTANCE P-LIKE MATERIALS FROM RAT SPINAL-CORD SLICES
    BOURGOIN, S
    POHL, M
    MAUBORGNE, A
    BENOLIEL, JJ
    COLLIN, E
    HAMON, M
    CESSELIN, F
    [J]. NEUROPHARMACOLOGY, 1993, 32 (07) : 633 - 640
  • [6] BRAAS KM, 1986, J NEUROSCI, V6, P1952
  • [7] Adenosine A1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons
    Carruthers, AM
    Sellers, LA
    Jenkins, DW
    Jarvie, EM
    Feniuk, W
    Humphrey, PPA
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (06) : 1533 - 1541
  • [8] BASIC AND REGULATORY MECHANISMS OF INVITRO RELEASE OF MET-ENKEPHALIN FROM THE DORSAL ZONE OF THE RAT SPINAL-CORD
    CESSELIN, F
    BOURGOIN, S
    ARTAUD, F
    HAMON, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 1984, 43 (03) : 763 - 774
  • [9] OPIOID AND ANTI-OPIOID PEPTIDES
    CESSELIN, F
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (05) : 409 - 433
  • [10] CHOCA JI, 1987, J PHARMACOL EXP THER, V242, P905